Navigation Links
Misonix Adds 6 Spine Sales Agencies In The U.S.
Date:8/7/2012

FARMINGDALE, N.Y., Aug. 7, 2012 /PRNewswire/ -- Misonix, Inc. (NasdaqGM: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has entered into new, multi-year agency agreements with six leading regional spine surgery sales organizations for the marketing of the Misonix® BoneScalpel™ Ultrasonic Bone Cutting System.  The agreements are indicative of the Company's commitment to capitalize on the growing clinical use of the BoneScalpel in advanced spine surgery procedures.  Each agreement is performance based with each agency committing to certain levels of sales. Product training has been completed and open market sales have commenced.

Included in the sales line-up are upstate New York-based Premier Orthopedic Solutions, Las Vegas-based Trinity Medical, Gilbert Medical of Virginia, NKB Medical located in Birmingham, AL, Florida based Manatee Medical, and Excella Medical, which is located in southern California.  Each of these organizations has a proven history of launching state-of-the-art spine products into their respective markets, including implantable spine hardware, biologics and sealants.

Bruce Tanner, Agency Principal for Premier Orthopedic Solutions, Inc., said, "We are excited to partner with Misonix.  Their BoneScalpel™ Ultrasonic Bone Cutting System provides our surgeons with a safe, precise and efficient way to remove bone during delicate spine surgery procedures.  Additionally, it allows us to represent a valuable, state-of-the-art technology to surgeons for whom we have not been able to offer a differentiating product in the past. Partnering with Misonix helps us to further enhance our reputation as premier sales consultants."

The BoneScalpel is a tissue specific osteotomy device capable of safely making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.  It offers the convenience and speed of a power instrument without the danger associated with rotary sharps as represented by saws and drills. The BoneScalpel's use in hospitals worldwide for numerous procedures in spine and skull-based surgery is on the rise.

"We are excited to have high-caliber agencies such as these join our growing family of market segment specific sales organizations in the United States; their presence demonstrates our commitment to capitalizing on large market opportunities like spine surgery.  We are aware of their past records of successfully introducing new spine products to their markets," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.  "We are very pleased that they will bring their market presence and sales expertise to the clinical proliferation of BoneScalpel."

About MisonixMisonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

Safe Harbor StatementWith the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.Investor Relations Contacts Misonix Contact:

Lytham Partners, LLCRichard Zaremba

Robert Blum, Joe Dorame, Joe Diaz631-694-9555

602-889-9700invest@misonix.com 

mson@lythampartners.com


'/>"/>
SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
2. Misonix Inks New Distribution Agreement For Croatia And Slovenia
3. Misonix And Soelim Create New Distribution Alliance For South Korea
4. Misonix Participates In Cleveland Spine Review
5. Misonix Adds Industry Veteran To Management Team
6. Misonix Exhibits at Major Worldwide Spine Conference
7. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy
8. Misonix Announces New Distribution Agreement For Panama
9. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
10. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
11. Spine Pain Management Opens Two Additional Affiliate Diagnostic Centers in Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc (NASDAQ: ... agreements to resolve virtually all known U.S. mesh product ... to resolve the known remaining U.S. claims at reasonable ... beginning in the fourth quarter of 2017 and continuing ... its second quarter 2017 results, the Company intends to ...
(Date:8/2/2017)... BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital in ... team to proactively reduce the risk of hospital-acquired infections (HAIs). The new addition, Tru-D ... UVC light energy to kill deadly pathogens such as C. diff , MRSA, MERS, ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)... 31, 2017 Three Tru-D SmartUVC robots have arrived ... Korea . Tru-D, short for "Total Room Ultraviolet Disinfection," is a ... an environmental services (ES) professional cleans the area with traditional cleaning protocols. ... Tru-D fights germs ... "Although the BAACH has a very ...
Breaking Medicine Technology:
(Date:8/20/2017)... ... August 20, 2017 , ... State Farm Neighborhood Assist® ... national causes up for a $25,000 grant. If the initiative wins, Gals Lead – ... will expand into the Tri-County area of St. Mary’s, Calvert and Charles Counties. The ...
(Date:8/19/2017)... ... August 18, 2017 , ... ... a transparent, verifiable database to help the cannabis industry move towards greater legitimacy. ... to deliver a faster technology with lower fees. Paragon will build a fully ...
(Date:8/19/2017)... ... August 19, 2017 , ... Praeclarus Press has launched ... illustrations show the diversity of the breastfeeding mothers, using bright colors and ... sizes. These illustrations are also available on tote bags, notepads, smartphone cases, clocks, ...
(Date:8/19/2017)... ... 19, 2017 , ... “Congratulations! It's A Boy! God’s Gift: A Story of ... and God. “Congratulations! It's A Boy! God’s Gift: A Story of Love” is the ... New York. , Published by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):